BRIEF published on 11/06/2025 at 07:11, 28 days 22 hours ago Commerzbank Achieves Record Operating Result in Nine Months Operating Results Commerzbank Financial Growth Cost-income Ratio Net Interest Income
PRESS RELEASE published on 11/06/2025 at 07:06, 28 days 22 hours ago Commerzbank continues growth trajectory: Record operating result after nine months Commerzbank reports record operating results after nine months, with revenues up 11% to €9bn and operating result increasing by 21% to €3.4bn. Cost-income ratio improved to 56% below target of 57% Revenues Operating Results Commerzbank Cost-income Ratio Growth Trajectory
BRIEF published on 11/06/2025 at 07:05, 28 days 22 hours ago Commerzbank Achieves Record Operating Result After Nine Months Revenue Growth Share Buyback Commerzbank Operating Result Cost-income Ratio
PRESS RELEASE published on 11/06/2025 at 07:00, 28 days 22 hours ago Commerzbank continues growth trajectory: Record operating result after nine months Commerzbank achieves record operating result of €3.4bn after nine months, with profits and revenues up. Bank remains on growth path with positive developments and strategic targets Revenues Financial Results Commerzbank Operating Result Growth Trajectory
BRIEF published on 11/03/2025 at 18:05, 1 month 1 day ago Postponement of the Publication of Eurasia Group's 2025 Half-Year Financial Report Financial Report Report Publication EURASIA GROUP Project Transformation Quality Information
BRIEF published on 10/30/2025 at 20:05, 1 month 5 days ago Ecoslops unveils its 2025 half-year financial report Financial Report Euronext Growth Circular Economy Ecoslops Micro-refining
BRIEF published on 10/30/2025 at 15:58, 1 month 5 days ago Commerzbank's SREP Capital Requirements Reduced for 2026 Commerzbank Capital Reduction CET1 Ratio European Central Bank SREP Requirements
BRIEF published on 10/30/2025 at 15:55, 1 month 5 days ago Commerzbank's SREP Capital Requirements Reduced for 2026 Commerzbank CET1 Ratio SREP Capital Requirements Pillar 2 Capital ECB Decision
PRESS RELEASE published on 10/30/2025 at 15:53, 1 month 5 days ago SREP capital requirements for Commerzbank reduced for 2026 – distance to MDA threshold remains comfortable Commerzbank's SREP capital requirements for 2026 reduced by 10 basis points to 2.15%. CEO Orlopp cites supervisors' confidence in the bank's business model Commerzbank CET1 Ratio Business Model Supervisory Authorities SREP Capital Requirements
PRESS RELEASE published on 10/30/2025 at 15:50, 1 month 5 days ago SREP capital requirements for Commerzbank reduced for 2026 – distance to MDA threshold remains comfortable Commerzbank's SREP capital requirements reduced for 2026, maintaining comfortable distance to MDA threshold. CEO Orlopp emphasizes confidence in business model and growth path Commerzbank CET1 Ratio Supervisory Authorities MDA Threshold SREP Capital Requirements
Published on 12/05/2025 at 02:35, 2 hours 49 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 24 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 19 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 24 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 54 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 33 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 59 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 9 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 13 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 24 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 39 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 40 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 23 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
